EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Incretin Mimetics and Alcohol‐Related Outcomes: A Structured Narrative Review

Christopher Goodyear iD, Eric Mensah, Autumn Stewart-Lynch iD, Jordan R Covvey iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026

DOI: 10.1002/phar.70206 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2026. Verfasst von Christopher Goodyear und 3 weiteren Autor:innen. Beteiligte Einrichtung: Duquesne University School of Pharmacy, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Incretins, Alcoholism. Die Arbeit nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Harmful alcohol use results in negative health outcomes for millions of patients each year, with limited effective treatment options available for those diagnosed with alcohol use disorder (AUD). Incretin mimetics, such as glucagon‐like‐peptide‐1 receptor agonists (GLP‐1RAs) and dual glucose‐dependent insulinotropic polypeptide/GLP‐1RAs (GIP/GLP‐1RAs), have garnered interest for their positive effects across a host of conditions beyond type 2 diabetes mellitus (T2DM); this includes substance use, where interactions between GLP‐1, dopamine modulation, and other neuroinflammatory mechanisms suggest potential benefit. Accordingly, this structured narrative review details evidence related to the role of incretin mimetics for alcohol‐related outcomes. Relevant pathophysiology is explored, as well as 21 observational and experimental clinical studies in this area. Literature suggests that incretin mimetics offer an opportunity for a shift in how medicine approaches AUD, leveraging multifaceted pathology to reduce alcohol consumption, craving intensity, health care utilization, and alcohol‐related complications. However, substantial gaps remain in establishing their place in therapy as a pharmacotherapeutic option in AUD and understanding the nuanced role that these agents may offer to addiction medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsAlcoholismHumansGlucagon-Like Peptide-1 Receptor AgonistsAnimals

Stichwörter der Autor:innen

alcohol drinkingalcoholismglucagon‐like peptide 1glucagon‐like peptide‐1 receptor agonists

Substanzen

IncretinsGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Duquesne University School of Pharmacy, Pittsburgh, Pennsylvania, USA.
  • Heritage Valley Family Medicine, Beaver Falls, Pennsylvania, USA.

ORCID-Profile: Christopher Goodyear, Autumn Stewart-Lynch, Jordan R Covvey

Zitieren

APA

Goodyear, C., Mensah, E., Stewart-Lynch, A., & Covvey, J. R. (2026). Incretin Mimetics and Alcohol‐Related Outcomes: A Structured Narrative Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.70206

Vancouver

Goodyear C, Mensah E, Stewart-Lynch A, Covvey JR. Incretin Mimetics and Alcohol‐Related Outcomes: A Structured Narrative Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026. doi:10.1002/phar.70206

BibTeX
@article{Goodyear2026,
  author = {Goodyear, Christopher and Mensah, Eric and Stewart-Lynch, Autumn and Covvey, Jordan R},
  title = {Incretin Mimetics and Alcohol‐Related Outcomes: A Structured Narrative Review},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2026},
  doi = {10.1002/phar.70206}
}
Kostenlos starten →